1 completed. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Completed 1 |
Follow nirsevimab: new trials by email Literature Review of nirsevimab trials Research Report on nirsevimab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Immunology and Safety of Maternal RSV Vaccination (ABRYSVO), Infant Nirsevimab (BEYFORTUS) Immunization, or Both Products Abrysvo, Beyfortus - Respiratory Syncytial Virus Infection | Phase 4 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 181 | 2024-09-19 | 2026-05-11 |
Respiratory Syncytial Virus Infections (1)
National Institute of Allergy and Infectious Diseases (NIAID) (1)
United States (1)
5UM1AI148684-04 (1)